Background Anthracyclines are potent chemotherapeutics burdened by their cardiotoxicity.
So far no marker to detect early cardiac damage exists. We tested the ability of magnetic …

Anthracyclines have been used in cancer treatment since the late 1960s and are frequently
used in current pediatric and adult treatment protocols. This therapy is based on an …

BACKGROUND: Pediatric cancer survivors who have been exposed to anthracycline (ANT)
chemotherapy are an ever increasing population at risk for premature cardiac disease …

Objective The M-mode-derived left ventricular shortening fraction is incorporated into most of
the paediatric oncology protocols for monitoring of cardiotoxicity. This study tested the …

Anthracycline chemotherapy (AC) is associated with impaired left ventricular (LV) systolic
function. LV ejection fraction (EF%) obtained by two-dimensional echocardiography is the …

Aims The aim of this study was to study changes in coronary microcirculation status during
and after several cycles of anthracycline treatment. Methods and results Large-white male …

Aims The aim of this study was to investigate myocardial 2D strain echocardiography and
cardiac biomarkers in the assessment of cardiac function in children with acute …

Purpose Childhood cancer survivors treated with anthracyclines and cardiac radiation are at
risk for late-onset cardiotoxicity. The purpose of this study was to delineate the relationship …

Despite major advances in cancer treatment, anthracycline-related cardiotoxicity remains a
major cause of morbidity and mortality in survivors of childhood cancer. Promising areas of …

Objectives: This study sought to evaluate whether patterns of myocardial change in
doxorubicin-induced dilated cardiomyopathy determined using dual-energy computed …